Skip to content

Effect of Contact Lenses on Tear Osmolarity in a Controlled Low Humidity Chamber

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01482312
Enrollment
29
Registered
2011-11-30
Start date
2010-12-31
Completion date
2011-02-28
Last updated
2012-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia, Dry Eye

Brief summary

The purpose of this study is to evaluate two different types of contact lenses and their effect on dry eyes when compared to wearing glasses in a controlled, low humidity chamber.

Interventions

Commercially marketed, silicone hydrogel, single-vision, soft contact lenses FDA-approved for daily and extended (overnight) wear for up to 30 nights of continuous wear.

Commercially marketed, silicone hydrogel, single-vision, soft contact lenses FDA-approved for daily and extended (overnight) wear for up to 30 nights of continuous wear.

OTHERGlasses

Glasses per habitual prescription

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 70. * History of end-of-day or low-humidity dryness with contact lenses. * Healthy eyes. * Best-corrected visual acuity of 20/50 or better for each eye. * Usable pair of eye glasses. * Willing and able to attend required study visits. * Sign informed consent. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Ocular or systemic allergies or diseases which might interfere with contact lens wear. * Clinically significant ocular findings which would contraindicate contact lens wear. * Unable to abstain from artificial tears or other ophthalmic drops for at least 7 days. * Participation in another clinical study currently or within 30 days of study entry. * Spectacle astigmatism of \>1.00 diopter. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Tear Osmolarity90 minutesThe participant spent 90 minutes in the LHE (low humidity environment) chamber, after which tears were sampled from the lower tear meniscus (thin strip of tear fluid at the lower lid margin) and tear osmolarity was measured using a TearLab osmometer, a device that measures the osmolarity of human tears to aid in the diagnosis of dry eye disease. Tear osmolarity is the measure of solid particles (salt) in a solution (tears), and a higher number can be indicative of dry eye disease, while a lower number is generally indicative of the normal tear osmolarity.
Ocular Comfort90 minutesOcular comfort was assessed by the participant after 90 minutes in the LHE and quantified as a linear measure (cm) on a modified Visual Analog Scale (VAS) of 0-20 cm, with a higher number indicating greater perceived comfort.

Countries

Canada

Participant flow

Recruitment details

Twenty-nine participants were randomized into one of three treatment sequences. The study took place at one site, which was located in Canada.

Pre-assignment details

Participants were instructed to use glasses as a washout from their habitual contact lens brand for at least seven days prior to initiating the first of three LHE (Low-Humidity Environment) chamber visits. This reporting group consists of all enrolled participants.

Participants by arm

ArmCount
Overall
This reporting group includes all enrolled participants.
29
Total29

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Period 1, 90 Minutes of WearOther100
Period 2, 90 Minutes of WearOther100

Baseline characteristics

CharacteristicOverall
Age Continuous44.3 years
STANDARD_DEVIATION 12.7
Sex: Female, Male
Female
21 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 280 / 270 / 27
serious
Total, serious adverse events
0 / 280 / 270 / 27

Outcome results

Primary

Ocular Comfort

Ocular comfort was assessed by the participant after 90 minutes in the LHE and quantified as a linear measure (cm) on a modified Visual Analog Scale (VAS) of 0-20 cm, with a higher number indicating greater perceived comfort.

Time frame: 90 minutes

Population: As treated.

ArmMeasureValue (MEDIAN)Dispersion
Lotrafilcon A Contact LensesOcular Comfort9.4 cmStandard Deviation 3.98
Comfilcon A Contact LensesOcular Comfort8.2 cmStandard Deviation 3.3
GlassesOcular Comfort9.7 cmStandard Deviation 3.53
Primary

Tear Osmolarity

The participant spent 90 minutes in the LHE (low humidity environment) chamber, after which tears were sampled from the lower tear meniscus (thin strip of tear fluid at the lower lid margin) and tear osmolarity was measured using a TearLab osmometer, a device that measures the osmolarity of human tears to aid in the diagnosis of dry eye disease. Tear osmolarity is the measure of solid particles (salt) in a solution (tears), and a higher number can be indicative of dry eye disease, while a lower number is generally indicative of the normal tear osmolarity.

Time frame: 90 minutes

Population: As treated.

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon A Contact LensesTear Osmolarity310 mOsms/LStandard Deviation 11
Comfilcon A Contact LensesTear Osmolarity313 mOsms/LStandard Deviation 9
GlassesTear Osmolarity306 mOsms/LStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026